Cargando…
Serum Selenium Level and 10-Year Survival after Melanoma
Melanoma is one of the most aggressive human malignancies. The determination of prognostic biomarkers is important for the early detection of recurrence and for the enrollment of the patients into different treatment regimens. Herein, we report the 10-year survival of 375 melanoma patients depending...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392027/ https://www.ncbi.nlm.nih.gov/pubmed/34440195 http://dx.doi.org/10.3390/biomedicines9080991 |
_version_ | 1783743410011635712 |
---|---|
author | Rogoża-Janiszewska, Emilia Malińska, Karolina Baszuk, Piotr Marciniak, Wojciech Derkacz, Róża Lener, Marcin Jakubowska, Anna Cybulski, Cezary Huzarski, Tomasz Masojć, Bartłomiej Gronwald, Jacek Rudnicka, Helena Kram, Andrzej Kiedrowicz, Magdalena Boer, Magdalena Dębniak, Tadeusz Lubiński, Jan |
author_facet | Rogoża-Janiszewska, Emilia Malińska, Karolina Baszuk, Piotr Marciniak, Wojciech Derkacz, Róża Lener, Marcin Jakubowska, Anna Cybulski, Cezary Huzarski, Tomasz Masojć, Bartłomiej Gronwald, Jacek Rudnicka, Helena Kram, Andrzej Kiedrowicz, Magdalena Boer, Magdalena Dębniak, Tadeusz Lubiński, Jan |
author_sort | Rogoża-Janiszewska, Emilia |
collection | PubMed |
description | Melanoma is one of the most aggressive human malignancies. The determination of prognostic biomarkers is important for the early detection of recurrence and for the enrollment of the patients into different treatment regimens. Herein, we report the 10-year survival of 375 melanoma patients depending on their serum selenium levels. The study group was followed up from the date of melanoma diagnosis until death or 2020. Patients were assigned to one of four categories, in accordance with the increasing selenium level (I–IV quartiles). The subgroup with low selenium levels had a significant lower survival rate in relation to patients with high selenium levels, HR = 8.42; p = 0.005 and HR = 5.83; p = 0.02, for uni- and multivariable models, respectively. In the univariable analysis, we also confirmed the association between Breslow thickness, Clark classification and age at melanoma prognosis. In conclusion, a low serum selenium level was associated with an increased mortality rate in the 10 years following melanoma diagnosis. Future studies in other geographic regions with low soil selenium levels should be conducted to confirm our findings. |
format | Online Article Text |
id | pubmed-8392027 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83920272021-08-28 Serum Selenium Level and 10-Year Survival after Melanoma Rogoża-Janiszewska, Emilia Malińska, Karolina Baszuk, Piotr Marciniak, Wojciech Derkacz, Róża Lener, Marcin Jakubowska, Anna Cybulski, Cezary Huzarski, Tomasz Masojć, Bartłomiej Gronwald, Jacek Rudnicka, Helena Kram, Andrzej Kiedrowicz, Magdalena Boer, Magdalena Dębniak, Tadeusz Lubiński, Jan Biomedicines Communication Melanoma is one of the most aggressive human malignancies. The determination of prognostic biomarkers is important for the early detection of recurrence and for the enrollment of the patients into different treatment regimens. Herein, we report the 10-year survival of 375 melanoma patients depending on their serum selenium levels. The study group was followed up from the date of melanoma diagnosis until death or 2020. Patients were assigned to one of four categories, in accordance with the increasing selenium level (I–IV quartiles). The subgroup with low selenium levels had a significant lower survival rate in relation to patients with high selenium levels, HR = 8.42; p = 0.005 and HR = 5.83; p = 0.02, for uni- and multivariable models, respectively. In the univariable analysis, we also confirmed the association between Breslow thickness, Clark classification and age at melanoma prognosis. In conclusion, a low serum selenium level was associated with an increased mortality rate in the 10 years following melanoma diagnosis. Future studies in other geographic regions with low soil selenium levels should be conducted to confirm our findings. MDPI 2021-08-11 /pmc/articles/PMC8392027/ /pubmed/34440195 http://dx.doi.org/10.3390/biomedicines9080991 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Communication Rogoża-Janiszewska, Emilia Malińska, Karolina Baszuk, Piotr Marciniak, Wojciech Derkacz, Róża Lener, Marcin Jakubowska, Anna Cybulski, Cezary Huzarski, Tomasz Masojć, Bartłomiej Gronwald, Jacek Rudnicka, Helena Kram, Andrzej Kiedrowicz, Magdalena Boer, Magdalena Dębniak, Tadeusz Lubiński, Jan Serum Selenium Level and 10-Year Survival after Melanoma |
title | Serum Selenium Level and 10-Year Survival after Melanoma |
title_full | Serum Selenium Level and 10-Year Survival after Melanoma |
title_fullStr | Serum Selenium Level and 10-Year Survival after Melanoma |
title_full_unstemmed | Serum Selenium Level and 10-Year Survival after Melanoma |
title_short | Serum Selenium Level and 10-Year Survival after Melanoma |
title_sort | serum selenium level and 10-year survival after melanoma |
topic | Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392027/ https://www.ncbi.nlm.nih.gov/pubmed/34440195 http://dx.doi.org/10.3390/biomedicines9080991 |
work_keys_str_mv | AT rogozajaniszewskaemilia serumseleniumleveland10yearsurvivalaftermelanoma AT malinskakarolina serumseleniumleveland10yearsurvivalaftermelanoma AT baszukpiotr serumseleniumleveland10yearsurvivalaftermelanoma AT marciniakwojciech serumseleniumleveland10yearsurvivalaftermelanoma AT derkaczroza serumseleniumleveland10yearsurvivalaftermelanoma AT lenermarcin serumseleniumleveland10yearsurvivalaftermelanoma AT jakubowskaanna serumseleniumleveland10yearsurvivalaftermelanoma AT cybulskicezary serumseleniumleveland10yearsurvivalaftermelanoma AT huzarskitomasz serumseleniumleveland10yearsurvivalaftermelanoma AT masojcbartłomiej serumseleniumleveland10yearsurvivalaftermelanoma AT gronwaldjacek serumseleniumleveland10yearsurvivalaftermelanoma AT rudnickahelena serumseleniumleveland10yearsurvivalaftermelanoma AT kramandrzej serumseleniumleveland10yearsurvivalaftermelanoma AT kiedrowiczmagdalena serumseleniumleveland10yearsurvivalaftermelanoma AT boermagdalena serumseleniumleveland10yearsurvivalaftermelanoma AT debniaktadeusz serumseleniumleveland10yearsurvivalaftermelanoma AT lubinskijan serumseleniumleveland10yearsurvivalaftermelanoma |